Table 7. Distribution of VAV2 rs602990 genotypes among obese (BMI > 30) and non-obese (BMI 25–30) patients.
| SNP | Genotype | Obesity | P value | OR (95% CI) | |||
|---|---|---|---|---|---|---|---|
| Yes |
No |
||||||
| N | % | N | % | ||||
| VAV2 rs602990 | CC | 31 | 25.6 | 54 | 27.4 | Ref. | 1.000 |
| CT | 52 | 43.0 | 102 | 51.8 | 0.814 | 0.935 (0.533–1.639) | |
| TT | 38 | 31.4 | 41 | 20.8 | 0.109 | 1.679 (0.890–3.165) | |
| VAV2 rs602990 dominant | CC | 31 | 25.6 | 54 | 27.4 | Ref. | 1.000 |
| CT + TT | 90 | 74.4 | 143 | 72.6 | 0.603 | 1.149 (0.682–1.936) | |
| VAV2 rs602990 recessive | CC + CT | 83 | 68.6 | 156 | 79.2 | Ref. | 1.000 |
| TT | 38 | 31.4 | 41 | 20.8 | 0.036 | 1.753 (1.038–2.958) | |
P value & OR adjusted by sex and age. CI = confidence interval; OR = odd ratio; ref. = reference; SNP = single nucleotide polymorphism.